BridgeBio Pharma (BBIO)

Director Kumar Neil 🔴 sold 80.0K shares of BridgeBio Pharma, Inc. (BBIO) at $78.19 ($6.0M) Transaction Date: Jan 08, 2026 | Filing ID: 000026

Zymeworks Inc (ZYME)

Smith Jeffrey T L 🟡 adjusted position in 9.3K shares (1 derivative) of Zymeworks Inc. (ZYME) at $22.67 Transaction Date: Jan 12, 2026 | Filing ID: 010865

Zymeworks Inc (ZYME)

Ciongoli Gregory Austin 🟢 acquired 19.2K shares (2 derivative) of Zymeworks Inc. (ZYME) at $23.16 Transaction Date: Jan 12, 2026 | Filing ID: 010864

Zymeworks Inc (ZYME)

Neu Kelvin 🟢 acquired 19.2K shares (2 derivative) of Zymeworks Inc. (ZYME) at $23.16 Transaction Date: Jan 12, 2026 | Filing ID: 010860

Zymeworks Inc (ZYME)

Landry Robert E 🟢 acquired 19.2K shares (2 derivative) of Zymeworks Inc. (ZYME) at $23.16 Transaction Date: Jan 12, 2026 | Filing ID: 010859

Zymeworks Inc (ZYME)

Cesano Alessandra 🟢 acquired 19.2K shares (2 derivative) of Zymeworks Inc. (ZYME) at $23.16 Transaction Date: Jan 12, 2026 | Filing ID: 010856

Enhabit Inc (EHAB)

Director Schochet Barry P. 🟢 acquired 2.4K shares of Enhabit, Inc. (EHAB) at $9.97 Transaction Date: Jan 10, 2026 | Filing ID: 000002

Zymeworks Inc (ZYME)

Campoy Carlos 🟢 acquired 19.2K shares (2 derivative) of Zymeworks Inc. (ZYME) at $23.16 Transaction Date: Jan 12, 2026 | Filing ID: 010852

Enhabit Inc (EHAB)

Director Rodgers Stephan 🟢 acquired 1.9K shares of Enhabit, Inc. (EHAB) at $9.97 Transaction Date: Jan 10, 2026 | Filing ID: 000002